TPC3- COST OF AML TREATMENT IN BELGIUM- RESULTS OF A RANDOMIZED TRIAL WITH AND WITHOUT FILGRASTIM USE
Sep 1, 1999, 00:00 AM
10.1016/S1098-3015(10)75830-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)75830-7/fulltext
Section Title :
Section Order :
76
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75830-7&doi=10.1016/S1098-3015(10)75830-7